N-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: Clinical observations and mechanistic insights

John K. Wachira, Mark K. Larson, William Harris

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

n-3 Fatty acids (EPA and DHA, from fish oil) are essential fatty acids that are approved for the treatment of severe hypertriacylglycerolaemia and, in some countries, used for reducing the risk of CVD. Because of their inhibitory effects on platelet function, some practitioners have, perhaps unnecessarily, discontinued their use in patients undergoing invasive procedures or being treated with anti-platelet or anticoagulation drugs. Thus, the aim of the present study was to review the effects of n-3 fatty acids on bleeding complications in a wide variety of clinical settings, and to summarise their biochemical mechanism of action in platelet function and coagulation. We surveyed recent publications that either directly studied the effects of n-3 fatty acids on the risk of bleeding or focused on different end-points and also reported the effects on bleeding. n-3 Fatty acid treatment had no effect on the risk of clinically significant bleeding in either monotherapy or combination therapy settings. Although originally believed to operate primarily via the cyclo-oxygenase system, these fatty acids have been shown to affect multiple signalling pathways and thrombotic processes beyond simply affecting platelet aggregation. The present overview found no support for discontinuing the use of n-3 fatty acid treatment before invasive procedures or when given in combination with other agents that affect bleeding. On the contrary, the use of these fatty acids in several settings improved clinical outcomes.

Original languageEnglish (US)
Pages (from-to)1652-1662
Number of pages11
JournalBritish Journal of Nutrition
Volume111
Issue number9
DOIs
StatePublished - May 14 2014
Externally publishedYes

Fingerprint

Omega-3 Fatty Acids
Hemostasis
Hemorrhage
Blood Platelets
Essential Fatty Acids
Fish Oils
Therapeutics
Prostaglandin-Endoperoxide Synthases
Platelet Aggregation
Fatty Acids
Pharmaceutical Preparations

Keywords

  • Bleeding
  • DHA
  • EPA
  • Fish oil
  • Haemostasis
  • n-3 Fatty acids
  • Thrombosis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

N-3 Fatty acids affect haemostasis but do not increase the risk of bleeding : Clinical observations and mechanistic insights. / Wachira, John K.; Larson, Mark K.; Harris, William.

In: British Journal of Nutrition, Vol. 111, No. 9, 14.05.2014, p. 1652-1662.

Research output: Contribution to journalArticle

Wachira, John K. ; Larson, Mark K. ; Harris, William. / N-3 Fatty acids affect haemostasis but do not increase the risk of bleeding : Clinical observations and mechanistic insights. In: British Journal of Nutrition. 2014 ; Vol. 111, No. 9. pp. 1652-1662.
@article{fe667b6bd72a412fb73c75f4ccc9043b,
title = "N-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: Clinical observations and mechanistic insights",
abstract = "n-3 Fatty acids (EPA and DHA, from fish oil) are essential fatty acids that are approved for the treatment of severe hypertriacylglycerolaemia and, in some countries, used for reducing the risk of CVD. Because of their inhibitory effects on platelet function, some practitioners have, perhaps unnecessarily, discontinued their use in patients undergoing invasive procedures or being treated with anti-platelet or anticoagulation drugs. Thus, the aim of the present study was to review the effects of n-3 fatty acids on bleeding complications in a wide variety of clinical settings, and to summarise their biochemical mechanism of action in platelet function and coagulation. We surveyed recent publications that either directly studied the effects of n-3 fatty acids on the risk of bleeding or focused on different end-points and also reported the effects on bleeding. n-3 Fatty acid treatment had no effect on the risk of clinically significant bleeding in either monotherapy or combination therapy settings. Although originally believed to operate primarily via the cyclo-oxygenase system, these fatty acids have been shown to affect multiple signalling pathways and thrombotic processes beyond simply affecting platelet aggregation. The present overview found no support for discontinuing the use of n-3 fatty acid treatment before invasive procedures or when given in combination with other agents that affect bleeding. On the contrary, the use of these fatty acids in several settings improved clinical outcomes.",
keywords = "Bleeding, DHA, EPA, Fish oil, Haemostasis, n-3 Fatty acids, Thrombosis",
author = "Wachira, {John K.} and Larson, {Mark K.} and William Harris",
year = "2014",
month = "5",
day = "14",
doi = "10.1017/S000711451300425X",
language = "English (US)",
volume = "111",
pages = "1652--1662",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "9",

}

TY - JOUR

T1 - N-3 Fatty acids affect haemostasis but do not increase the risk of bleeding

T2 - Clinical observations and mechanistic insights

AU - Wachira, John K.

AU - Larson, Mark K.

AU - Harris, William

PY - 2014/5/14

Y1 - 2014/5/14

N2 - n-3 Fatty acids (EPA and DHA, from fish oil) are essential fatty acids that are approved for the treatment of severe hypertriacylglycerolaemia and, in some countries, used for reducing the risk of CVD. Because of their inhibitory effects on platelet function, some practitioners have, perhaps unnecessarily, discontinued their use in patients undergoing invasive procedures or being treated with anti-platelet or anticoagulation drugs. Thus, the aim of the present study was to review the effects of n-3 fatty acids on bleeding complications in a wide variety of clinical settings, and to summarise their biochemical mechanism of action in platelet function and coagulation. We surveyed recent publications that either directly studied the effects of n-3 fatty acids on the risk of bleeding or focused on different end-points and also reported the effects on bleeding. n-3 Fatty acid treatment had no effect on the risk of clinically significant bleeding in either monotherapy or combination therapy settings. Although originally believed to operate primarily via the cyclo-oxygenase system, these fatty acids have been shown to affect multiple signalling pathways and thrombotic processes beyond simply affecting platelet aggregation. The present overview found no support for discontinuing the use of n-3 fatty acid treatment before invasive procedures or when given in combination with other agents that affect bleeding. On the contrary, the use of these fatty acids in several settings improved clinical outcomes.

AB - n-3 Fatty acids (EPA and DHA, from fish oil) are essential fatty acids that are approved for the treatment of severe hypertriacylglycerolaemia and, in some countries, used for reducing the risk of CVD. Because of their inhibitory effects on platelet function, some practitioners have, perhaps unnecessarily, discontinued their use in patients undergoing invasive procedures or being treated with anti-platelet or anticoagulation drugs. Thus, the aim of the present study was to review the effects of n-3 fatty acids on bleeding complications in a wide variety of clinical settings, and to summarise their biochemical mechanism of action in platelet function and coagulation. We surveyed recent publications that either directly studied the effects of n-3 fatty acids on the risk of bleeding or focused on different end-points and also reported the effects on bleeding. n-3 Fatty acid treatment had no effect on the risk of clinically significant bleeding in either monotherapy or combination therapy settings. Although originally believed to operate primarily via the cyclo-oxygenase system, these fatty acids have been shown to affect multiple signalling pathways and thrombotic processes beyond simply affecting platelet aggregation. The present overview found no support for discontinuing the use of n-3 fatty acid treatment before invasive procedures or when given in combination with other agents that affect bleeding. On the contrary, the use of these fatty acids in several settings improved clinical outcomes.

KW - Bleeding

KW - DHA

KW - EPA

KW - Fish oil

KW - Haemostasis

KW - n-3 Fatty acids

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84898008385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898008385&partnerID=8YFLogxK

U2 - 10.1017/S000711451300425X

DO - 10.1017/S000711451300425X

M3 - Article

C2 - 24472372

AN - SCOPUS:84898008385

VL - 111

SP - 1652

EP - 1662

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 9

ER -